HRES848FEDERALin_committee

Supporting U.S. Participation in Gavi Vaccine Initiatives

Original title: Supporting the role of the United States in helping save the lives of children and protecting the health of people in low-income countries with vaccines and immunization through Gavi, the Vaccine Alliance ("Gavi").

October 31, 2025

global health vaccines foreign aid child health Gavi

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced

Committee

Floor Vote

Passed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action

Referred to the House Committee on Foreign Affairs.Oct 31, 2025

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This resolution signals Congressional intent to continue U.S. funding and diplomatic support for Gavi, which impacts the allocation of federal foreign aid dollars toward global health programs.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

U.S. Taxpayers

Federal tax dollars are used to fund U.S. contributions to Gavi.

Gavi-supported countries

These nations receive vaccine procurement support and health system strengthening resources.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This House resolution expresses formal support for the United States' ongoing partnership with Gavi, the Vaccine Alliance. It highlights the organization's success in increasing global immunization rates and reducing childhood mortality in low-income countries.

Key Facts

Gavi has supported the immunization of over 1.1 billion children and averted an estimated 18.8 million deaths between 2000 and 2023.
Gavi-eligible countries contributed over $1.7 billion to immunization campaigns between 2008 and 2023.
Gavi's market-shaping efforts reduced the price of common vaccines by 24% between 2015 and 2020.
The number of global vaccine manufacturers selling to Gavi-supported countries increased from 5 in 2001 to 19 in 2023.
Gavi estimates market-shaping efforts will result in over $900 million in savings from 2021 to 2025.
Gavi plans to provide 50 million malaria vaccine doses to children during the 2026-2030 strategic cycle.
Every $1 invested in Gavi-supported countries returns over $54 in health and economic savings.
19 countries have transitioned out of Gavi support as of 2022, with 10 more potentially transitioning by 2040.
Gavi delivered nearly 2 billion COVID-19 vaccine doses to 146 economies through the COVAX program.

Why It Matters

This resolution signals Congressional intent to continue U.S. funding and diplomatic support for Gavi, which impacts the allocation of federal foreign aid dollars toward global health programs.

Frequently Asked Questions

Does this resolution authorize new spending?

No, this is a resolution expressing support for the program; it does not independently appropriate new federal funds.

What is Gavi's role in malaria prevention?

Gavi is procuring and delivering new malaria vaccines, with a goal of providing 50 million doses to children between 2026 and 2030.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Transitioning Countries

The document highlights a clear trend of countries graduating from Gavi support, with 19 having transitioned by 2022 and 10 more expected by 2040.

Gavi, the Vaccine Alliance

Connected Entities

personBrian Fitzpatrick“U.S. Representative and co-sponsor.”Map →

organizationCenters for Disease Control and Prevention“U.S. agency that collaborates with Gavi.”Map →

personMichael Lawler“U.S. Representative and co-sponsor.”Map →

organizationBill & Melinda Gates Foundation“A founding partner of Gavi.”Map →

organizationGavi, the Vaccine Alliance“A public-private global health partnership focused on increasing access to vacci”Map →

personMaria Elvira Salazar“U.S. Representative and co-sponsor.”Map →

personThomas Kean“U.S. Representative who introduced the resolution.”Map →

personGabe Amo“U.S. Representative and co-sponsor.”Map →

Analysis Score

0–100

Significance40
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz15
Current news / social attention level

Publisher tools